Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
Total raised: $25M
Funding Rounds 1
Date | Series | Amount | Investors |
06.12.2024 | - | $25M | - |
Mentions in press and media 1
Date | Title | Description |
06.12.2024 | Liom secures $25 million to advance its non-invasive glucose monitoring device | Founded in 2017 by serial entrepreneur Leo Grünstein, Liom, with offices in Pfäffikon SZ and San Francisco has raised over USD 55m in equity funding to-date and employs a team of >80 FTE. The company has kicked-off a USD 50-70m Series A... |